Regulatory Briefs: User Fees Set For FY 2014, Glucose Strip Recall
This article was originally published in The Gray Sheet
Executive Summary
FDA announces its medical device user fees for fiscal year 2014. Nova Diabetes Care recalls up to 62 million blood glucose test strips. More regulatory news.